Phase 1 dose-escalation and pharmacokinetic study of regorafenib in paediatric patients with recurrent or refractory solid malignancies-Reference-Cited by-同舟云学术

Phase 1 dose-escalation and pharmacokinetic study of regorafenib in paediatric patients with recurrent or refractory solid malignancies

Published:2021-08 Issue: Volume:153 Page:142-152
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Geoerger Birgit^ORCID,Morland Bruce,Jiménez Irene,Frappaz Didier^ORCID,Pearson Andrew D.J.^ORCID,Vassal Gilles,Maeda Patricia,Kincaide Jasmine,Mueller Udo,Schlief Sarah,Teufel Michael,Ploeger Bart A.,Cleton Adriaan,Agostinho Andrea C.,Marshall Lynley V.

Funder

Bayer HealthCare AG

Bayer

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference50 articles.

1. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma;Chan;Am J Surg Pathol,1998

2. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas;Eggert;Clin Cancer Res,2000

3. Upregulation of vascular endothelial growth factor receptors is associated with advanced neuroblastoma;Fakhari;J Pediatr Surg,2002

4. Expression of angiogenic factors and tumor progression in human neuroblastoma;Komuro;J Cancer Res Clin Oncol,2001

5. Angiogenesis of glioma: evaluation of ultrastructural characteristics of microvessels and tubular bodies (Weibel-Palade) in endothelial cells and immunohistochemical findings with VEGF and p53 protein;Miyagami;Med Mol Morphol,2005

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A study of Some Factors Affecting the Prevalence of Renal Disease in Children;Al-Kitab Journal for Pure Sciences;2024-06-09

2. What are the Optimal Systemic Treatment Options for Rhabdomyosarcoma?;Current Treatment Options in Oncology;2024-05-16

3. Safety of Off-Label Use of Anticancer Drugs in Oncology;Creative surgery and oncology;2024-04-18

4. A Study of Some Immunological and Hematological Aspects in Children with Renal Disease;Journal of Prospective Researches;2024-04-09

5. Frontline and Relapsed Rhabdomyosarcoma (FAR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG);Cancers;2024-02-29